U.S. Ambulatory Surgical Centers Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
U.S. ambulatory surgical centers market size was valued at around USD 38.9 billion in 2023 and is expected to grow at a CAGR of 3.6% from 2024 to 2032. Favorable reimbursement policies and supportive government initiatives are crucial drivers of the growth of the ASC market in the U.S.
The Centers for Medicare & Medicaid Services (CMS) have expanded the list of procedures that can be performed in ASCs and are eligible for reimbursement. This includes many minimally invasive surgeries, which are increasingly popular due to shorter recovery times and lower costs.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
U.S. Ambulatory Surgical Centers Market Size in 2023: | USD 38.9 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2023 - 2032 CAGR: | 3.6 |
2023 Value Projection: | USD 54.4 Billion |
Historical Data for: | 2021-2023 |
No of Pages: | 100 |
Tables, Charts & Figures: | 27 |
Segments Covered: | Ownership, Surgery Type, Specialty Type, and Service |
Growth Drivers: |
|
Pitfalls Challenges: |
|
For instance, according to the Medicare Payment Advisory Commission (MedPAC), the number of Medicare-certified ASCs has grown steadily, with over 5,800 ASCs in operation as of 2022, reflecting the increasing utilization driven by favorable reimbursement policies. These policies ensure that ASCs receive adequate compensation for their services, making them a cost-effective and high-quality alternative to hospital-based surgeries. The ongoing expansion of covered procedures, competitive payment rates, and the alignment with value-based care models further bolster the demand for ASCs in the country, contributing to their rapid growth and widespread adoption in the healthcare system.
Ambulatory surgical centers (ASCs) are specialized healthcare facilities that focus on providing elective surgical procedures to patients who do not require overnight hospitalization. These centers are designed to accommodate procedures that can be safely performed in an outpatient setting, allowing patients to undergo surgery and return home on the same day after a brief recovery period.
The availability of minimally invasive treatments is a major driver of growth for the market. Technological advancements, patient preferences, cost efficiency, and supportive regulatory and insurance policies all contribute to this trend.
By ownership, the market is categorized into physician only, hospital only, corporation only, physician & hospital, physician & corporation, and hospital & corporation. The physician only segment dominated the market with a revenue of around USD 22 billion in 2023.
By surgery type, the U.S. ambulatory surgical centers market is categorized into dental, otolaryngology, endoscopy, obstetrics/gynecology, ophthalmology, orthopedic, cardiovascular, neurology, plastic surgery, podiatry, and others surgery types. The ophthalmology segment is anticipate dominating the market with the revenue of USD 9.8 billion in 2032.
By specialty type, the U.S. ambulatory surgical centers market is categorized into multi-specialty and single specialty. The single speciality segment anticipated to dominate the market with the revenue of 21.9 billion in 2023.
By services, the U.S. ambulatory surgical centers market is categorized into diagnosis and treatment. The treatment segment dominated the market with a revenue of around USD 29.3 billion in 2023.
U.S. ambulatory surgical centres industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of new services are key market strategies for the U.S. ambulatory surgical centers service providers, driving competition and innovation in the industry. This emphasis on innovation aims to address evolving needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for advanced U.S. ambulatory surgical centers and services.
Some of the eminent market participants operating in the U.S. ambulatory surgical centers industry include:
Market, By Ownership
Market, By Surgery Type
Market, By Specialty Type
Market, By Service
The single specialty segment is expected to dominate the market with a revenue of USD 21.9 billion in 2023, as physicians and staff develop a high level of expertise in their specific field, resulting in higher quality care and better patient outcomes.
The ophthalmology segment is anticipated to dominate the market with a projected revenue of USD 9.8 billion by 2032, driven by the high prevalence of age-related eye conditions such as cataracts, glaucoma, and macular degeneration.
U.S. ambulatory surgical centers industry was valued at approximately USD 38.9 billion in 2023 and is expected to grow at a 3.6% CAGR from 2024 to 2032, driven by favorable reimbursement policies and supportive government initiatives.